Carrie Brownstein's Net Worth
$520 Thousand
Who is Carrie Brownstein?
Carrie Brownstein does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Shattuck Labs, Inc., and Zentalis Pharmaceuticals, Inc..
SEC CIK
Carrie Brownstein's CIK is 0001894232
Past Insider Trading and Trends
2022 was Carrie Brownstein's most active year for acquiring shares with 4 total transactions. Carrie Brownstein's most active month to acquire stocks was the month of September. 2023 was Carrie Brownstein's most active year for disposing of shares, totalling 2 transactions. Carrie Brownstein's most active month to dispose stocks was the month of September. 2022 saw Carrie Brownstein paying a total of $0.00 for 540,258 shares, this is the most they've acquired in one year. In 2023 Carrie Brownstein cashed out on 10,628 shares for a total of $207,297.77, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Shattuck Labs, Inc. (STTK) Snapshot price: $3.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Zentalis Pharmaceuticals, Inc. (ZNTL) Snapshot price: $2.96
Chief Medical OfficerCarrie Brownstein owns 105,685 units of Common Stock which is worth $312,827.60. In the year 2022 Carrie Brownstein acquired a total of 116,313 shares in Zentalis Pharmaceuticals, Inc., Carrie also disposed a total of 10,628 shares of Zentalis Pharmaceuticals, Inc. equalling to $207,297.77.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.14% | -10.63K |
$19.50 | -$207,297.77 | 105.69K |
Oct 4
| |||
Form 4
| +16.31% | 16.31K |
—
|
—
| 116.31K |
Feb 1
| |||
Form 4
|
∞
| 100K |
—
|
—
| 100K |
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||